SM
NBSE
Sabby Management’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-152,127
| Closed | -$110K | – | 130 |
|
|
2017
Q3 | $110K | Sell |
152,127
-529,173
| -78% | -$383K | 0.01% | 65 |
|
|
2017
Q2 | $436K | Sell |
681,300
-828,015
| -55% | -$530K | 0.03% | 69 |
|
|
2017
Q1 | $1.25M | Buy |
1,509,315
+352,922
| +31% | +$293K | 0.07% | 37 |
|
|
2016
Q4 | $1.74M | Buy |
+1,156,393
| New | +$1.74M | 0.1% | 31 |
|
|
2015
Q3 | – | Sell |
-89,982
| Closed | -$226K | – | 246 |
|
|
2015
Q2 | $226K | Sell |
89,982
-105,258
| -54% | -$264K | 0.01% | 126 |
|
|
2015
Q1 | $496K | Buy |
195,240
+145,240
| +290% | +$369K | 0.02% | 98 |
|
|
2014
Q4 | $417 | Sell |
50,000
-29,300
| -37% | -$244 | 0.01% | 88 |
|
|
2014
Q3 | $575 | Sell |
79,300
-19,500
| -20% | -$141 | 0.02% | 71 |
|
|
2014
Q2 | $940K | Buy |
+98,800
| New | +$940K | 0.04% | 66 |
|